Express Pharma

Bayer to close $62.5 bn Monsanto takeover deal


Monsanto will no longer be a company name

Germany’s Bayer will wrap up the $62.5 billion takeover of Monsanto this week and also retire the name of the US seeds maker, it said on Monday. The German drugmaker had received all required approvals from regulatory authorities, it said in a statement.

“Bayer will remain the company name. Monsanto will no longer be a company name. The acquired products will retain their brand names and become part of the Bayer portfolio,” it said. Bayer launched a 6 billion euro ($7 billion) rights issue on Sunday, a cornerstone of the financing package for the deal.



Comments are closed.